Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.0%

2 terminated out of 67 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

4%

3 trials in Phase 3/4

Results Transparency

13%

3 of 24 completed with results

Key Signals

3 with results92% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (25)
P 1 (2)
P 2 (6)
P 4 (3)

Trial Status

Completed24
Recruiting18
Unknown14
Withdrawn3
Not Yet Recruiting3
Terminated2

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (67)

Showing 20 of 20 trials
NCT07083700Not ApplicableRecruitingPrimary

Frame Support Study

NCT05271981Completed

Fertility After Uterine Artery Embolization

NCT06293235Recruiting

Towards Optimal Fertility, Fathering and Fatherhood studY

NCT05172999Phase 2Completed

Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

NCT05285670Not ApplicableActive Not Recruiting

Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower)

NCT05842070Not ApplicableCompletedPrimary

The Stanford Egg Freezing Study

NCT06043609Recruiting

Outcome Evaluation After Fertility Preservation

NCT05080569Phase 4Recruiting

Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment

NCT05555121Phase 2SuspendedPrimary

Rescue Progesterone Supplementation During Frozen Embryo Transfer

NCT05176535Not ApplicableCompleted

Determination of Vaginal Colonization and the Effect of an Oral Probiotic (PROSALVAG)

NCT05048654Withdrawn

A Novel Ovarian Reserve Monitoring Algorithm for Patients at Risk of Ovarian Injury From Gonadotoxic Therapy

NCT06387498Not ApplicableRecruitingPrimary

Testicular Tissue Cryopreservation (TTC)

NCT06664034Not ApplicableRecruiting

Intervening on Women's Health for Rural Young Cancer Survivors

NCT05316493Phase 2Recruiting

Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

NCT05316467Phase 2Recruiting

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

NCT06834945Not ApplicableCompleted

Addressing Fertility Information Needs and Distress

NCT06297070CompletedPrimary

Lifestyle Care for Fertility Outcome Evaluation

NCT07050537Not ApplicableRecruitingPrimary

A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology

NCT05815719Phase 4CompletedPrimary

Continuous Double Ovarian Stimulation.

NCT05858307Recruiting

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

Scroll to load more

Research Network

Activity Timeline